Administration of Bamlanivimab to Skilled Nursing Facility Residents During a COVID-19 Outbreak, January-February 2021, Arizona
- PMID: 34000267
- PMCID: PMC8096193
- DOI: 10.1016/j.jamda.2021.04.023
Administration of Bamlanivimab to Skilled Nursing Facility Residents During a COVID-19 Outbreak, January-February 2021, Arizona
References
-
- COVID-19 news release: FDA authorizes monoclonal antibody for treatment of COVID-19. US Food and Drug Administration website. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19... Available at: Published November 9, 2020.
-
- Coronavirus (COVID-19) update: FDA authorizes monoclonal antibodies for treatment of COVID-19. US Food and Drug Administration website. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19... Available at: Published November 21, 2021.
-
- Special Projects for Equitable and Efficient Distribution (SPEED) of COVID-19 Outpatient Therapeutics. US Office of the Assistant Secretary for Preparedness & Response. https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Pages/SPE... Available at: Published March 9, 2021.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
